​IMV is Aiming to Take Immunotherapy to the Next Level

Spotlight Companies | |

Here's how IMV is shifting the paradigm in immunotherapy.

ImmunoGen Presents Positive Data on Ovarian Cancer Treatment

Edward Kim | |

Encouraging signs of efficacy and favorable safety profile in platinum-resistant ovarian cancer (Image: Cancer Therapy Advisor)

​Why IMV Wants You to Rethink What You Know About Immunotherapy — Q&A with CEO Frederic Ors

Spotlight Companies | |

What sets IMV's technology apart is that it essentially aims to re-engineer immune system responses to deliver a desired effect, creating a new mechanism of action.

​Healthy Bets in Oncology: Bristol-Myers Squibb and AstraZeneca

MoneyShow | |

Two leading players in the pharmaceutical sector present opportunities in the space of oncology.

​How Immunovaccine is Leading a New Frontier in the Fight Against Cancer

Spotlight Companies | |

The company's revolutionary DepoVax™ platform makes it a key player in the future of cancer treatments.

​Why Immunovaccine Ranks Among Top 10 Best Performing OTCQX Companies

Spotlight Companies | |

Here's what's behind the company's impressive streak.

​Immunovaccine’s DepoVax™ Continues to Play a Pivotal Role in the Future of Modern Medicine

Spotlight Companies | |

With its innovative DepoVax™ platform, Immunovaccine is quickly emerging as a leading name in the immunotherapy and cancer vaccine space of the life sciences sector.

​Value Expert Steps Up to Biogen and Merck After Setbacks

MoneyShow | |

Does this pair of healthcare stocks still have upside potential?

​While Distracted By Lynparza, Markets Missed This AstraZeneca PLC (AZN) Development

Mark Collins | |

Here's a look at some secondary but still important news from AZN today.

​OncoSec Is Steadily Taking Its Place as a Leader in Immuno-Oncology

Spotlight Companies | |

The company continues to string one milestone after another.

Sponsored Financial Content

Market Movers